PDCD1 and neoplasm: The authors hypothesize that this might be due to a variety of potential mechanisms (Fig. 1), including: improved affinity of truncated PD1 to PDL1, simultaneous blockade of alternative PD1 ligands, such as PDL2, or increased diffusion of truncated PD1 through the tumor due to its smaller size.